Cytosorbents Cor (CTSO)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] by (Cboe BZX)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] [[ item.lastPriceExt ]] [[ item.priceChangeExt ]] ([[ item.percentChangeExt ]]) [[ item.tradeTimeExt ]]
for [[ item.sessionDateDisplayLong ]]
Fiscal Year End Date: 12/31
| 12-2010 | 12-2009 | 12-2008 | 12-2007 | 12-2006 | |
| Operating Expenses | 2,810 | 3,020 | 1,980 | 3,060 | 2,960 |
| Operating Income | -2,810 | -3,020 | -1,980 | -3,060 | -2,960 |
| Interest Expense | 80 | 8 | 0 | 0 | 4,730 |
| Other Income | -10 | -2 | 0 | -290 | 20 |
| Pre-tax Income | -2,900 | -3,030 | -1,980 | -3,350 | -7,670 |
| Income Tax | 0 | -290 | N/A | 0 | 0 |
| Net Income Continuous | -2,900 | -2,740 | -1,980 | -3,350 | -7,670 |
| Net Income | $-2,900 | $-2,730 | $-1,980 | $-3,350 | $-7,670 |
| EBITDA(a) | $-2,750 | $-2,970 | $-1,880 | $-2,870 | $-1,710 |